July 14, 2023

FDA Approves Over-the-Counter Birth Control Pill for All Ages

On July 13, the US Food and Drug Administration (FDA) announced its approval of the first over-the-counter birth control pill. The drug will be available to all ages starting in February 2024.

The FDA approved the drug Opill (manufactured by the Irish company Perrigo) to be sold without a prescription. The pill is intended to be taken at the same time each day.

Like Plan B, Opill is a progestin-based drug. The drug is intended to prevent pregnancy by preventing sperm from reaching the cervix. However, even though Biden's FDA amended Plan B's label to state otherwise, the drug can function as an abortifacient.

Dr. Donna Harrison with the American Association of Pro-Life Obstetricians and Gynecologists wrote for the National Review, “If Plan B is taken five to two days before egg release is due to happen, the interference with the LH signal prevents a woman from releasing an egg, no fertilization happens, and no embryo is formed.” She continues that issues can occur if the pills are taken during a “two-day window when embryos can form but positive pregnancy tests don't occur.”

She cites studies suggesting that Plan B “has a likely embryocidal effect in stopping pregnancy,” if taken during that two-day window.

LiveAction also cited several studies suggesting that women who take progestin-only contraceptives are at increased health risks of breast cancer, cervical cancer, brain cancer, and ectopic pregnancy.

The FDA found progestin-only contraception can also cause the following side effects: headaches, dizziness, nausea, increased appetite, abdominal pain, cramps and bloating, fatigue, painful periods, nervousness, backache, breast discomfort, acne, and depression.